- 不活性化ワクチン
- 令和
- ドイツ
- 新型肺炎
- 実験室
- 記者
- 抽出
- 新型コロナウイルス感染症
- 陰圧
- 分析
- 報道写真・映像トップ 報道写真・映像トップ
- 写真・グラフィックス・映像 | 写真・グラフィックス・映像 |
「不活性」の写真・グラフィックス・映像
- 提供元
- 日付
- 種類
- 向き
- カテゴリ
- 色
- 提供元
- 共同通信社 0
- 国内提供元 0
- 海外提供元 0
- 日付
- 24時間以内 0
- 48時間以内 0
- 72時間以内 0
- 7日以内 0
- 30日以内 0
- 1年以内 29
- 期間を指定 368
- 日付指定なし 368
- 種類
- 写真 364
- グラフィックス 0
- 映像 4
- 向き
- 縦 24
- 横 344
- 正方形 0
- カテゴリ
- ニュース
- スポーツ
- エンターテインメント
- 教育向け
- カテゴリ指定なし
- 色
- カラー 367
- モノクロ 1
- 古い順
- 1
- 2
- 3
- 4
- 古い順
本画像はログイン後にご覧いただけます
-Sandro Botticelli (1445-1510), was an Italian painter of the Early Renaissance.Sandro Botticelli (1445-1510), was an Italian painter of the Early Renaissance. The Lamentation over the Dead Christ. Inert body of Christ surrounded by the Virgin, St. Peter and Mary Magdalene, St. John the Evangelist, St. Jerome and St. Paul. Alte Pinakothek. Munich. Germany.、クレジット:Album/Prisma/共同通信イメージズ ※エディトリアル使用のみ。表紙、広告、プロモーション、商業目的での利用はお問合せください。クレジットは必ず表記してください。
商品コード: 2020060200733
本画像はログイン後にご覧いただけます
-Peter Paul Rubens (1577-1640).Peter Paul Rubens (1577-1640). Flemish painter. The lamentation over the dead Christ, 1610-1611. Oil on panel. Gemaldegalerie. Berlin. Germany.、クレジット:Album/Prisma/共同通信イメージズ ※エディトリアル使用のみ。表紙、広告、プロモーション、商業目的での利用はお問合せください。クレジットは必ず表記してください。
商品コード: 2020033002545
本画像はログイン後にご覧いただけます
1919年12月31日John William StruttJohn William Strutt, 3rd Baron Rayleigh (1842-1919) British physicist. Nobel Prize for Physics 1904. Discovered the element Argon, one of the noble (inert) gases. Cartoon from ‘Vanity Fair‘, London, December 1899, showing him lecturing.、クレジット:World History Archive/ニューズコム/共同通信イメージズ ※エディトリアル使用のみ。広告、プロモーション、商業目的での利用はできません。
商品コード: 2019071708170
本画像はログイン後にご覧いただけます
1987年10月01日Eliminating chemical munitions at Shikhany military facility01.10.1987 Eliminating stockpiles of chemical weapons. Preparing to demonstrate a process for eliminating a chemical munition at the Shikhany military facility. At the invitation of the Soviet Government, representatives of the UN, delegations from 45 countries, parties to the talks, and observer states at the Shikhany military chemical facility. Andrew、クレジット:Sputnik/共同通信イメージズ
商品コード: 2023011400504
- 本画像はログイン後にご覧いただけます1996年02月07日切り取り作業 もんじゅ冷却材漏れ事故
空気を遮断し不活性ガスが注入された覆いに囲まれた配管で行われる温度検出器部分の切り取り作業=7日午前10時33分、福井県敦賀市白木の高速増殖炉原型炉もんじゅ(代表撮影)
商品コード: 1996020700026
- 本画像はログイン後にご覧いただけます1996年02月07日切り取り作業 もんじゅ冷却材漏れ事故
空気を遮断し不活性ガスが注入された覆いに囲まれた配管で行われる温度検出器部分の切り取り作業=7日午前10時33分、福井県敦賀市白木の高速増殖炉原型炉もんじゅ(代表撮影)
商品コード: 1996020700027
本画像はログイン後にご覧いただけます
2019年06月13日Bomb defusing in Oranienburg - evacuation of local residents13 June 2019, Brandenburg, Oranienburg: Pascal Lehmann, firefighter at the Germendorf Volunteer Fire Brigade, rings the bell at a house in Oranienburg during the evacuation of the bomb deactivation circuit. Two world war bombs are to be defused on Thursday (13.06.2019) in Oranienburg. For the work on the industrial site not far from the railway station, a barrier circuit of around 1000 metres will be set up from 8.00 a.m.. Photo: Christoph Soeder/dpa、クレジット:DPA/共同通信イメージズ
商品コード: 2019061402625
本画像はログイン後にご覧いただけます
2019年07月06日Unexploded bomb deactivation - evacuation06 July 2019, Hessen, Frankfurt/Main: One of a total of 25 coma awake patients is taken from a nursing home by rescue workers and pushed into an ambulance in the run-up to tomorrow‘s planned defusing of a World War II bomb. Around 16,500 people have to leave their homes on Sunday for security reasons. In addition to residential areas, the restricted area also includes railway lines, federal roads, the European Central Bank (ECB) and the Main river. The 500 kilogram American air bomb was discovered during construction work. Photo: Boris Roessler/dpa、クレジット:DPA/共同通信イメージズ
商品コード: 2019070905935
本画像はログイン後にご覧いただけます
2019年07月06日Unexploded bomb deactivation - evacuation06 July 2019, Hessen, Frankfurt/Main: One of a total of 25 coma awake patients is taken from a nursing home by rescue workers and pushed into an ambulance in the run-up to tomorrow‘s planned defusing of a World War II bomb. Around 16,500 people have to leave their homes on Sunday for security reasons. In addition to residential areas, the restricted area also includes railway lines, federal roads, the European Central Bank (ECB) and the Main river. The 500 kilogram American air bomb was discovered during construction work. Photo: Boris Roessler/dpa、クレジット:DPA/共同通信イメージズ
商品コード: 2019070905997
本画像はログイン後にご覧いただけます
2019年07月06日Unexploded bomb deactivation - evacuation06 July 2019, Hessen, Frankfurt/Main: A woman and her dog pass between ambulances in the evacuation zone. Around 16,500 people have to leave their homes on Sunday for security reasons. In addition to residential areas, the restricted area also includes railway lines, federal roads, the European Central Bank (ECB) and the Main river. The 500 kilogram American air bomb was discovered during construction work. Photo: Boris Roessler/dpa、クレジット:DPA/共同通信イメージズ
商品コード: 2019070906106
本画像はログイン後にご覧いただけます
2019年07月06日Unexploded bomb deactivation - evacuation06 July 2019, Hessen, Frankfurt/Main: While she is being pushed to an ambulance on a stretcher, a patient is holding her cuddly toy. A total of 25 coma vigil patients were brought out of a nursing home by rescue workers in the run-up to the planned defusing of a world war bomb tomorrow. Around 16,500 people have to leave their homes on Sunday for security reasons. In addition to residential areas, the restricted area also includes railway lines, federal roads, the European Central Bank (ECB) and the Main river. The 500 kilogram American air bomb was discovered during construction work. Photo: Boris Roessler/dpa、クレジット:DPA/共同通信イメージズ
商品コード: 2019070905988
本画像はログイン後にご覧いただけます
2019年07月06日Unexploded bomb deactivation - evacuation06 July 2019, Hessen, Frankfurt/Main: Ambulances are ready to bring a total of 25 coma awake patients from a nursing home in the run-up to tomorrow‘s planned defusing of a world war bomb by rescue forces. Around 16,500 people have to leave their homes on Sunday for security reasons. In addition to residential areas, the restricted area also includes railway lines, federal roads, the European Central Bank (ECB) and the Main river. The 500 kilogram American air bomb was discovered during construction work. Photo: Boris Roessler/dpa、クレジット:DPA/共同通信イメージズ
商品コード: 2019070906178
本画像はログイン後にご覧いただけます
2019年07月06日Unexploded bomb deactivation - evacuation06 July 2019, Hessen, Frankfurt/Main: One of a total of 25 coma awake patients is taken from a nursing home by rescue workers and pushed into an ambulance in the run-up to tomorrow‘s planned defusing of a World War II bomb. Around 16,500 people have to leave their homes on Sunday for security reasons. In addition to residential areas, the restricted area also includes railway lines, federal roads, the European Central Bank (ECB) and the Main river. The 500 kilogram American air bomb was discovered during construction work. Photo: Boris Roessler/dpa、クレジット:DPA/共同通信イメージズ
商品コード: 2019070906040
本画像はログイン後にご覧いただけます
2019年11月29日欲望が不活性な時代に「この世界の向こう側を見せてくれる解放感が、現代実在論にはある」と話す岩内章太郎さん
商品コード: 2019112900301
本画像はログイン後にご覧いただけます
2019年11月29日欲望が不活性な時代に「この世界の向こう側を見せてくれる解放感が、現代実在論にはある」と話す岩内章太郎さん
商品コード: 2019112900303
本画像はログイン後にご覧いただけます
2019年11月29日欲望が不活性な時代に初の単著「新しい哲学の教科書」を刊行した岩内章太郎さん
商品コード: 2019112900302
本映像はログイン後にご覧いただけます
01:55.712020年02月28日「新華社」正確に検体を採取できれば、核酸検出の精度は高い鍾南山院士新型コロナウイルスによる肺炎の感染が猛威を振るう中、核酸検出法の精度が人々の話題を集めている。中国工程院院士(アカデミー会員)の鍾南山(しょう・なんざん)氏はこのほど、広東省政府新聞弁公室の記者会見で、核酸検出を信頼すべきであり、比較的正確に検体を採取できれば、精度は高くなるはずだとし、この意味で検出率は正確だと説明した。検体は新型コロナウイルス専門の検査施設「火眼」実験室に送られた後、受領、開梱、不活性化、情報照合、仕分け、移送、核酸抽出、検出と増幅、解析リポートのレビューと配布など一連の工程を経る。不活性化が最も鍵となるプロセスであり、検査員は陰圧検査室で防護服を着用するだけでなく、関連するあらゆる操作を生物学的安全キャビネット内で行う必要がある。実験室の責任者は、100%の検出率を達成できる技術はなく、絶えずウイルスを知り、技術を改良するとともに、検出とモニタリングの頻度を高め続ける必要があるとの見解を示した。(記者/王作葵、潘志偉、董博涵)<映像内容>新型肺炎の検体を採取、「火眼」実験室の様子、撮影日:撮影日不明、クレジット:新華社/共同通信イメージズ
商品コード: 2020030203347
本画像はログイン後にご覧いただけます
2020年03月06日Coronavirus - Germany06 March 2020, Baden-Wuerttemberg, Singen am Hohentwiel: An employee of the Dr. Blessing laboratory prepares a sample tube for virus inactivation under the safety workbench. After virus inactivation under the safety cabinet, the tubes are transferred to another laboratory area for further processing. Photo: Felix Kästle/dpa、クレジット:DPA/共同通信イメージズ
商品コード: 2020030901450
本画像はログイン後にご覧いただけます
2020年03月06日深圳の研究者、新型コロナウイルス不活性後の形を描出6日、顕微鏡で描出した新型コロナウイルス不活化後の形状と、ウイルスが宿主細胞に侵入する中間状態。中国の深圳国家感染性疾病臨床医学研究センターと南方科技大学は6日、新型コロナウイルスによる肺炎の臨床症例から生体試料を採取し、クライオ電子顕微鏡を用いて新型コロナウイルス不活化後の実際の形状を描出し、ウイルスが宿主細胞に侵入する中間状態を捉えたことを共同で発表した。(深圳=新華社配信)=2020(令和2)年3月6日、クレジット:新華社/共同通信イメージズ
商品コード: 2020031004421
本画像はログイン後にご覧いただけます
2020年03月06日Coronavirus - Germany06 March 2020, Baden-Wuerttemberg, Singen am Hohentwiel: An employee of the Dr. Blessing laboratory fills a stand with various smear tubes. After virus inactivation under the safety cabinet, the tubes are moved to another laboratory area for further processing. Photo: Felix Kästle/dpa - ATTENTION: The names on the sample tubes were pixelated for legal reasons、クレジット:DPA/共同通信イメージズ
商品コード: 2020030901460
本画像はログイン後にご覧いただけます
2020年03月06日Coronavirus - Germany06 March 2020, Baden-Wuerttemberg, Singen am Hohentwiel: An employee of the Dr. Blessing laboratory holds a stand with various throat swab tubes in his hands. After virus inactivation under the safety cabinet, the tubes are moved to another laboratory area for further processing. Photo: Felix Kästle/dpa - ATTENTION: The names on the sample tubes were pixelated for legal reasons、クレジット:DPA/共同通信イメージズ
商品コード: 2020030901370
本画像はログイン後にご覧いただけます
2020年03月06日Testing for corona virus06 March 2020, Baden-Wuerttemberg, Singen Am Hohentwiel: An employee of the Dr. Blessing laboratory fills a stand with various smear tubes. After virus inactivation under the safety cabinet, the tubes are moved to another laboratory area for further processing. Photo: Felix Kästle/dpa、クレジット:DPA/共同通信イメージズ
商品コード: 2020040700063
本画像はログイン後にご覧いただけます
2020年03月06日Testing for corona virus06 March 2020, Baden-Wuerttemberg, Singen Am Hohentwiel: An employee of the Dr. Blessing laboratory fills a stand with various smear tubes. After virus inactivation under the safety cabinet, the tubes are moved to another laboratory area for further processing. Photo: Felix Kästle/dpa、クレジット:DPA/共同通信イメージズ
商品コード: 2020040603033
本画像はログイン後にご覧いただけます
2020年03月06日Coronavirus - Germany06 March 2020, Baden-Wuerttemberg, Singen am Hohentwiel: An employee of the Dr. Blessing laboratory holds a stand with various throat swab tubes in his hands. After virus inactivation under the safety cabinet, the tubes are moved to another laboratory area for further processing. Photo: Felix Kästle/dpa - ATTENTION: The names on the sample tubes were pixelated for legal reasons、クレジット:DPA/共同通信イメージズ
商品コード: 2020030901544
本画像はログイン後にご覧いただけます
2020年03月06日深圳の研究者、新型コロナウイルス不活性後の形を描出6日、深圳市第三人民医院バイオセーフティー3級実験室で研究するスタッフ。中国の深圳国家感染性疾病臨床医学研究センターと南方科技大学は6日、新型コロナウイルスによる肺炎の臨床症例から生体試料を採取し、クライオ電子顕微鏡を用いて新型コロナウイルス不活化後の実際の形状を描出し、ウイルスが宿主細胞に侵入する中間状態を捉えたことを共同で発表した。(深圳=新華社配信)=2020(令和2)年3月6日、クレジット:新華社/共同通信イメージズ ※ファイルサイズの小さい画像です。※画像が荒れています。
商品コード: 2020031004499
本画像はログイン後にご覧いただけます
2020年03月06日Testing for corona virus06 March 2020, Baden-Wuerttemberg, Singen Am Hohentwiel: An employee of the Dr. Blessing laboratory fills a stand with various smear tubes. After virus inactivation under the safety cabinet, the tubes are moved to another laboratory area for further processing. Photo: Felix Kästle/dpa、クレジット:DPA/共同通信イメージズ
商品コード: 2020040602931
本映像はログイン後にご覧いただけます
01:15.282020年05月23日「新華社」殺菌消毒率99%超ウイルスを不活性化する「米粒大」深紫外線LED深紫外線発光ダイオード(LED)チップは可視光線を出さないが、米粒ほどの大きさで細菌やウイルスのDNAとRNAを破壊できる。このチップから出る光は、通常の紫外線とは異なり、波長域が短く、人の皮膚にほとんどダメージを与えない。米粒大の深紫外線LEDチップは、さまざまな製品に組み込むことで、水や空気、物体表面の殺菌消毒が可能になり、その殺菌消毒率は99%を超える。中国山西省長治市では同市人民政府と中国科学院半導体研究所、石炭大手の潞安集団が共同で中科潞安深紫外LEDプロジェクトを進めている。深紫外線LEDのコア技術を利用して開発した一連の製品は、水質浄化や空気浄化、食品の鮮度保持、医療などの分野での幅広い応用が期待できる。(記者/馬志異)<映像内容>深紫外線LEDチップを使った殺菌消毒、撮影日:撮影日不明、クレジット:新華社/共同通信イメージズ
商品コード: 2020052701200
本画像はログイン後にご覧いただけます
2020年06月22日Breast milk bank is being built up22 June 2020, North Rhine-Westphalia, Essen: A bottle of donated breast milk is placed in a CMV virus inactivation device by lactation consultant Silke Kruse-Hähnel. If the mother of a premature baby has no milk of her own, the premature baby can be supplied with donated milk from the breast milk bank. Photo: Roland Weihrauch/dpa、クレジット:DPA/共同通信イメージズ
商品コード: 2020062503853
本画像はログイン後にご覧いただけます
2020年07月03日中日友好医院、PCR検査で各科の医療従事者が協力3日、中日友好医院で、PCR検査の不活性化した検体を運ぶ閆克芹さん。中国北京市の中日友好医院で勤務する、いつもならそれぞれ産婦人科実験室と薬物臨床試験研究センターに所属の閆克芹(えん・こくきん)さんと張鑫(ちょう・きん)さんは、今は新型コロナウイルス感染症の核酸検査(PCR検査)を支援するため一時的に結成された実験室チームの一員として働いている。2人が働く実験室では現在、1日あたり最大1万件の検査が可能。(北京=新華社記者/張玉薇)=2020(令和2)年7月3日、クレジット:新華社/共同通信イメージズ
商品コード: 2020070705423
本画像はログイン後にご覧いただけます
2020年07月28日Delhi‘s biggest landfill.in India - 28 Jul 2020July 28, 2020, Delhi, India: East Delhi Municipal Corporation (EDMC) use a trommel-cum-ballistic machine to separate solid waste and inert materials at Delhi‘s biggest landfill. (Credit Image: © Amarjeet Kumar Singh/SOPA Images via ZUMA Wire)、クレジット:©Amarjeet Kumar Singh/SOPA Images via ZUMA Wire/共同通信イメージズ
商品コード: 2020073103417
本画像はログイン後にご覧いただけます
2020年07月28日Delhi‘s biggest landfill.in India - 28 Jul 2020July 28, 2020, Delhi, India: East Delhi Municipal Corporation (EDMC) use a trommel-cum-ballistic machine to separate solid waste and inert materials at Delhi‘s biggest landfill. (Credit Image: © Amarjeet Kumar Singh/SOPA Images via ZUMA Wire)、クレジット:©Amarjeet Kumar Singh/SOPA Images via ZUMA Wire/共同通信イメージズ
商品コード: 2020080306296
本画像はログイン後にご覧いただけます
2020年07月28日Delhi‘s biggest landfill.in India - 28 Jul 2020July 28, 2020, Delhi, India: East Delhi Municipal Corporation (EDMC) use a trommel-cum-ballistic machine to separate solid waste and inert materials at Delhi‘s biggest landfill. (Credit Image: © Amarjeet Kumar Singh/SOPA Images via ZUMA Wire)、クレジット:©Amarjeet Kumar Singh/SOPA Images via ZUMA Wire/共同通信イメージズ
商品コード: 2020080306265
本画像はログイン後にご覧いただけます
2020年07月28日Delhi‘s biggest landfill.in India - 28 Jul 2020July 28, 2020, Delhi, India: East Delhi Municipal Corporation (EDMC) use a trommel-cum-ballistic machine to separate solid waste and inert materials at Delhi‘s biggest landfill. (Credit Image: © Amarjeet Kumar Singh/SOPA Images via ZUMA Wire)、クレジット:©Amarjeet Kumar Singh/SOPA Images via ZUMA Wire/共同通信イメージズ
商品コード: 2020080306254
本画像はログイン後にご覧いただけます
2020年07月28日Delhi‘s biggest landfill.in India - 28 Jul 2020July 28, 2020, Delhi, India: East Delhi Municipal Corporation (EDMC) use a trommel-cum-ballistic machine to separate solid waste and inert materials at Delhi‘s biggest landfill. (Credit Image: © Amarjeet Kumar Singh/SOPA Images via ZUMA Wire)、クレジット:©Amarjeet Kumar Singh/SOPA Images via ZUMA Wire/共同通信イメージズ
商品コード: 2020080306255
本画像はログイン後にご覧いただけます
2020年07月28日Delhi‘s biggest landfill.in India - 28 Jul 2020July 28, 2020, Delhi, India: East Delhi Municipal Corporation (EDMC) workers load garbage in a trommel-cum-ballistic machine used to separate solid waste and inert materials at Delhi‘s biggest landfill. (Credit Image: © Amarjeet Kumar Singh/SOPA Images via ZUMA Wire)、クレジット:©Amarjeet Kumar Singh/SOPA Images via ZUMA Wire/共同通信イメージズ
商品コード: 2020080306129
本画像はログイン後にご覧いただけます
2020年07月28日Delhi‘s biggest landfill.in India - 28 Jul 2020July 28, 2020, Delhi, India: East Delhi Municipal Corporation (EDMC) use a trommel-cum-ballistic machine to separate solid waste and inert materials at Delhi‘s biggest landfill. (Credit Image: © Amarjeet Kumar Singh/SOPA Images via ZUMA Wire)、クレジット:©Amarjeet Kumar Singh/SOPA Images via ZUMA Wire/共同通信イメージズ
商品コード: 2020080306228
本画像はログイン後にご覧いただけます
2020年07月28日Delhi‘s biggest landfill.in India - 28 Jul 2020July 28, 2020, Delhi, India: East Delhi Municipal Corporation (EDMC) use a trommel-cum-ballistic machine to separate solid waste and inert materials at Delhi‘s biggest landfill. (Credit Image: © Amarjeet Kumar Singh/SOPA Images via ZUMA Wire)、クレジット:©Amarjeet Kumar Singh/SOPA Images via ZUMA Wire/共同通信イメージズ
商品コード: 2020080306262
本画像はログイン後にご覧いただけます
2020年07月28日Delhi‘s biggest landfill.in India - 28 Jul 2020July 28, 2020, Delhi, India: East Delhi Municipal Corporation (EDMC) use a trommel-cum-ballistic machine to separate solid waste and inert materials at Delhi‘s biggest landfill. (Credit Image: © Amarjeet Kumar Singh/SOPA Images via ZUMA Wire)、クレジット:©Amarjeet Kumar Singh/SOPA Images via ZUMA Wire/共同通信イメージズ
商品コード: 2020080306251
本画像はログイン後にご覧いただけます
2020年07月28日Environment waste at Ghazipur Landfill site in New Delhi, India - 28 Jul 2020July 28, 2020, New Delhi, India: A trommel machine-cum-ballistic separators machine used to separate solid waste and inert materials at Ghazipur landfill site..Ghazipur landfill site was opened in 1984. Taking up space of more than 40 football pitches and nearly 2,000 tones of garbage is dumped at the site each day. Ghazipur landfill site is already more than 65 metres (213 feet) high. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ
商品コード: 2020073008009
本画像はログイン後にご覧いただけます
2020年07月28日Environment waste at Ghazipur Landfill site in New Delhi, India - 28 Jul 2020July 28, 2020, New Delhi, India: A worker smokes as he watches the Trommel machine separate solid waste and inert materials at Ghazipur landfill site..Ghazipur landfill site was opened in 1984. Taking up space of more than 40 football pitches and nearly 2,000 tones of garbage is dumped at the site each day. Ghazipur landfill site is already more than 65 metres (213 feet) high. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ
商品コード: 2020073007961
本画像はログイン後にご覧いただけます
2020年09月03日Routine TrainingSeptember 3, 2020 - Aviation Ordnanceman Airman Devin Fredrick, from Atlanta, assigned to the aircraft carrier USS Gerald R. Ford (CVN 78), installs an arming device on a MK-63 1,000-pound inert mine, Septembert. 3, 2020. Ford is underway in the Atlantic Ocean conducting an independent steaming event. (Credit Image: © Sarah MeadU.S. Navy/ZUMA Wire/ZUMAPRESS.com)、クレジット:©Sarah MeadU.S. Navy/ZUMA Wire/ZUMAPRESS.com/共同通信イメージズ
商品コード: 2020091804470
本画像はログイン後にご覧いただけます
2020年09月05日CHINA BEIJING SERVICE TRADE FAIRPeople learn about the inactivated SARS-CoV-2 Vaccine (Vero Cell) developed by China National Biotec Group (CNBG) during the China International Fair for Trade in Services in Beijing, China Saturday, Sept. 05, 2020. CNBG, a Sinopharm unit, has moved two vaccine strains using the same method into human trials.、クレジット:Featurechina/共同通信イメージズ ※中国での使用禁止。
商品コード: 2020091101286
本画像はログイン後にご覧いただけます
2020年10月05日New equipment for deactivators05 October 2020, Saxony-Anhalt, Magdeburg: A remote control manipulator from the Department for Unconventional Explosive and Fire Devices of the State Office of Criminal Investigation (LKA) Saxony-Anhalt stands next to the bomb disposal vehicle. Photo: Klaus-Dietmar Gabbert/dpa-Zentralbild/ZB、クレジット:ZB/DPA/共同通信イメージズ
商品コード: 2020101602689
本画像はログイン後にご覧いただけます
2020年10月05日New equipment for deactivators05 October 2020, Saxony-Anhalt, Magdeburg: During an exercise, a defuser from the Department of Unconventional Explosive and Fire Devices of the State Criminal Police Office (LKA) of Saxony-Anhalt walks along a defusing vehicle. In the foreground is Holger Stahlknecht (l., CDU), Minister of the Interior of Saxony-Anhalt. Photo: Klaus-Dietmar Gabbert/dpa-Zentralbild/ZB、クレジット:ZB/DPA/共同通信イメージズ
商品コード: 2020101603000
本画像はログイン後にご覧いただけます
2020年10月05日New equipment for deactivators05 October 2020, Saxony-Anhalt, Magdeburg: A new bomb disposal vehicle is parked on the premises of the State Criminal Police Office (LKA) of Saxony-Anhalt behind a barrier tape with the inscription “Polizeiabsperrung“. Next to it is a remote-controlled robot vehicle. The state procured the transporter worth 150,000 euros and the robot worth about 350,000 euros. The robot can both explore the surroundings for suspicious explosives and grab and handle things while being controlled from a safe distance. The new equipment was handed over to the Department of Unconventional Explosive and Fire Devices in the afternoon. Photo: Klaus-Dietmar Gabbert/dpa-Zentralbild/ZB、クレジット:ZB/DPA/共同通信イメージズ
商品コード: 2020100604513
本画像はログイン後にご覧いただけます
2020年10月05日New equipment for deactivators05 October 2020, Saxony-Anhalt, Magdeburg: A new remote-controlled robot vehicle of the Department for Unconventional Explosive and Fire Devices of the State Criminal Police Office (LKA) of Saxony-Anhalt approaches a “suspicious“ suitcase during an exercise. The state procured the robot worth around 350,000 euros. The robot can both explore the surroundings for suspicious explosives and grab and process things while being controlled from a safe distance. It was handed over to the Department of Unconventional Explosives and Fire Devices in the afternoon. Photo: Klaus-Dietmar Gabbert/dpa-Zentralbild/ZB、クレジット:ZB/DPA/共同通信イメージズ
商品コード: 2020100604522
本画像はログイン後にご覧いただけます
2020年10月05日New equipment for deactivators05 October 2020, Saxony-Anhalt, Magdeburg: A defuser from the Department for Unconventional Explosive and Fire Devices of the State Criminal Police Office (LKA) of Saxony-Anhalt approaches a suitcase during an exercise. Photo: Klaus-Dietmar Gabbert/dpa-Zentralbild/ZB、クレジット:ZB/DPA/共同通信イメージズ
商品コード: 2020101602661
本画像はログイン後にご覧いただけます
2020年10月05日New equipment for deactivators05 October 2020, Saxony-Anhalt, Magdeburg: A defuser of the department for unconventional explosive and incendiary devices of the State Office of Criminal Investigation (LKA) Saxony-Anhalt shows an illegal firecracker. Photo: Klaus-Dietmar Gabbert/dpa-Zentralbild/ZB、クレジット:ZB/DPA/共同通信イメージズ
商品コード: 2020101602748
本画像はログイン後にご覧いただけます
2020年10月05日New equipment for deactivators05 October 2020, Saxony-Anhalt, Magdeburg: A remote control manipulator of the Department for Unconventional Explosive and Fire Devices of the State Criminal Police Office (LKA) Saxony-Anhalt approaches a suspicious suitcase during an exercise. Photo: Klaus-Dietmar Gabbert/dpa-Zentralbild/ZB、クレジット:ZB/DPA/共同通信イメージズ
商品コード: 2020101602969
本画像はログイン後にご覧いただけます
2020年10月05日New equipment for deactivators05 October 2020, Saxony-Anhalt, Magdeburg: During an exercise, a defusing officer from the Department of Unconventional Explosive and Fire Devices of the State Criminal Police Office (LKA) of Saxony-Anhalt places a portable X-ray machine next to a “suspicious“ suitcase. The state of Saxony-Anhalt procured a transporter worth 150,000 euros for the police department, which is equipped with modern defusing technology. The state also procured a robot worth about 350,000 euros. This robot can both explore the surrounding area for suspicious explosives and grab and process things while being controlled from a safe distance. The new equipment was handed over to the Department of Unconventional Explosives and Fire Devices in the afternoon. Photo: Klaus-Dietmar Gabbert/dpa-Zentralbild/ZB、クレジット:ZB/DPA/共同通信イメージズ
商品コード: 2020100604364
本画像はログイン後にご覧いただけます
2020年10月05日New equipment for deactivators05 October 2020, Saxony-Anhalt, Magdeburg: During an exercise, a defusing officer from the Department of Unconventional Explosive and Fire Devices of the State Criminal Police Office (LKA) of Saxony-Anhalt places a “suspicious“ object in a secure transport container with a manipulator rod. The state of Saxony-Anhalt procured a transporter worth 150,000 euros for the police department, which is equipped with modern defusing technology. The state also procured a robot worth around 350,000 euros. This robot can both explore the surrounding area for suspicious explosives and grab and process things while being controlled from a safe distance. The new equipment was handed over to the Department of Unconventional Explosives and Fire Devices in the afternoon. Photo: Klaus-Dietmar Gabbert/dpa-Zentralbild/ZB、クレジット:ZB/DPA/共同通信イメージズ
商品コード: 2020100604301
本画像はログイン後にご覧いただけます
2020年10月05日New equipment for deactivators05 October 2020, Saxony-Anhalt, Magdeburg: During an exercise, a defusing officer from the Department of Unconventional Explosive and Fire Devices of the State Criminal Police Office (LKA) of Saxony-Anhalt grips a “suspicious“ object with a portable manipulator rod. The State of Saxony-Anhalt procured a transporter worth 150,000 euros for the police department, which is equipped with modern defusing technology. The state also procured a robot worth about 350,000 euros. This robot can both explore the surrounding area for suspicious explosives and grab and process things while being controlled from a safe distance. The new equipment was handed over to the Department of Unconventional Explosives and Fire Devices in the afternoon. Photo: Klaus-Dietmar Gabbert/dpa-Zentralbild/ZB、クレジット:ZB/DPA/共同通信イメージズ
商品コード: 2020100604682
本画像はログイン後にご覧いただけます
2020年10月12日Deactivation work of rockets in Stepanakert.October 12, 2020, Stepanakert, Nagorno Karabakh: Explosives deactivator walks near a deactivated azeri rocket in the outskirts of Stepanakert, Nagorno Karabakh. (Credit Image: © Celestino Arce Lavin/ZUMA Wire)、クレジット:©Celestino Arce Lavin/ZUMA Wire/共同通信イメージズ
商品コード: 2020101503347
本画像はログイン後にご覧いただけます
2020年10月12日Deactivation work of rockets in Stepanakert.October 12, 2020, Stepanakert, Nagorno Karabakh: Explosives deactivator walks over a deactivated azeri rocket in the outskirts of Stepanakert, capital of Nagorno Karabakh. (Credit Image: © Celestino Arce Lavin/ZUMA Wire)、クレジット:©Celestino Arce Lavin/ZUMA Wire/共同通信イメージズ
商品コード: 2020101502984
本画像はログイン後にご覧いただけます
2021年01月28日New Crown Vaccine For High Risk Population New Crown Vaccine For High Risk PopulationA medical worker shows Novel Coronavirus inactivated vaccine at an inoculation room of a hospital of traditional Chinese medicine in Rongan County, Liuzhou City, south China‘s Guangxi Zhuang Autonomous Region, Jan 28, 2021.=2021(令和3)年1月28日、クレジット:CFOTO/共同通信イメージズ
商品コード: 2021020306212
本画像はログイン後にご覧いただけます
2021年01月28日New Crown Vaccine For High Risk Population New Crown Vaccine For High Risk PopulationA medical worker shows Novel Coronavirus inactivated vaccine at an inoculation room of a hospital of traditional Chinese medicine in Rongan County, Liuzhou City, south China‘s Guangxi Zhuang Autonomous Region, Jan 28, 2021.=2021(令和3)年1月28日、クレジット:CFOTO/共同通信イメージズ
商品コード: 2021020306186
本画像はログイン後にご覧いただけます
2021年02月03日SWEDEN VALNEVA SWEDEN VALNEVAValneva a specialty vaccine company focused on prevention of infectious diseases in Stockholm, Sweden, February 03, 2021. Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Janerik Henriksson / TT / code 10010=2021(令和3)年2月3日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021020409281
本画像はログイン後にご覧いただけます
2021年02月03日SWEDEN VALNEVA SWEDEN VALNEVAValneva a specialty vaccine company focused on prevention of infectious diseases in Stockholm, Sweden, February 03, 2021. Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Janerik Henriksson / TT / code 10010=2021(令和3)年2月3日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021020409265
本画像はログイン後にご覧いただけます
2021年02月03日SWEDEN VALNEVA SWEDEN VALNEVAValneva a specialty vaccine company focused on prevention of infectious diseases in Stockholm, Sweden, February 03, 2021. Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Janerik Henriksson / TT / code 10010=2021(令和3)年2月3日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021020409286
本画像はログイン後にご覧いただけます
2021年02月03日SWEDEN VALNEVA SWEDEN VALNEVAValneva a specialty vaccine company focused on prevention of infectious diseases in Stockholm, Sweden, February 03, 2021. Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Janerik Henriksson / TT / code 10010=2021(令和3)年2月3日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021020409255
本画像はログイン後にご覧いただけます
2021年02月03日SWEDEN VALNEVA SWEDEN VALNEVAValneva a specialty vaccine company focused on prevention of infectious diseases in Stockholm, Sweden, February 03, 2021. Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Janerik Henriksson / TT / code 10010=2021(令和3)年2月3日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021020409253
本画像はログイン後にご覧いただけます
2021年02月03日SWEDEN VALNEVA SWEDEN VALNEVAValneva a specialty vaccine company focused on prevention of infectious diseases in Stockholm, Sweden, February 03, 2021. Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Janerik Henriksson / TT / code 10010=2021(令和3)年2月3日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021020409277
本画像はログイン後にご覧いただけます
2021年02月03日SWEDEN VALNEVA SWEDEN VALNEVAValneva a specialty vaccine company focused on prevention of infectious diseases in Stockholm, Sweden, February 03, 2021. Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Janerik Henriksson / TT / code 10010=2021(令和3)年2月3日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021020409262
本画像はログイン後にご覧いただけます
2021年02月03日SWEDEN VALNEVA SWEDEN VALNEVAValneva a specialty vaccine company focused on prevention of infectious diseases in Stockholm, Sweden, February 03, 2021. Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Janerik Henriksson / TT / code 10010=2021(令和3)年2月3日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021020409287
本画像はログイン後にご覧いただけます
2021年02月03日SWEDEN VALNEVA SWEDEN VALNEVAValneva a specialty vaccine company focused on prevention of infectious diseases in Stockholm, Sweden, February 03, 2021. Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Janerik Henriksson / TT / code 10010=2021(令和3)年2月3日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021020409280
本画像はログイン後にご覧いただけます
2021年02月03日SWEDEN VALNEVA SWEDEN VALNEVAValneva a specialty vaccine company focused on prevention of infectious diseases in Stockholm, Sweden, February 03, 2021. Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Janerik Henriksson / TT / code 10010=2021(令和3)年2月3日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021020409293
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907779
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907834
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907720
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907739
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907726
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907766
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907829
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907793
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907820
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907742
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907717
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907752
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907824
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907707
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907768
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907828
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907774
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907769
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907783
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907805
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907770
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907753
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907839
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907823
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907827
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907708
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907761
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907818
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907745
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907711
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907746
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907738
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907830
本画像はログイン後にご覧いただけます
2021年02月16日VALNEVA COVID-19 VACCINE VALNEVA COVID-19 VACCINEValneva Sweden AB is preparing to start production of their COVID-19 vaccine in Stockholm, Sweden, on February 16, 2021.Valneva is a specialty vaccine company focused on prevention of infectious diseases. The caompany has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.Photo: Henrik Montgomery / TT Code 10060 =2021(令和3)年2月16日、クレジット:TT News Agency/共同通信イメージズ
商品コード: 2021021907728
- 1
- 2
- 3
- 4
- 報道写真・映像トップ 報道写真・映像トップ
- 写真・グラフィックス・映像 | 写真・グラフィックス・映像 |